Mediation of endogenous β-Endorphin in the plasma glucose-lowering action of herbal products observed in type 1-like diabetic rats

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  Cheng, J T ^b   Liu, I M ^a  

^a TAJEN UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; BETA ENDORPHIN; GLUCOSE; GLUCOSE TRANSPORTER; HERBACEOUS AGENT; INSULIN; MU OPIATE RECEPTOR; PHOSPHOLIPASE C; PROTEIN KINASE;

ADRENAL GLAND; DISEASE SEVERITY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE UTILIZATION; HORMONE RELEASE; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW; STREPTOZOCIN DIABETES;

EID: 79251546063     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nen078     Document Type: Review

References (115)

1. Jeffcoate S. L., Diabetes control and complications: the role of glycated haemoglobin, 25 years on Diabetic Medicine 2004 21 7 657 665
2. Lindstrm J., Louheranta A., Mannelin M., Rastas M., Salminen V., Eriksson J., Uusitupa M., Tuomilehto J., The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity Diabetes Care 2003 26 12 3230 3236
3. Shamoon H., Duffy H., Fleischer N., Engel S., Saenger P., Strelzyn M., Litwak M., Wylie-Rosett J., Farkash A., Geiger D., Engel H., Fleischman J., Pompi D., Ginsberg N., Glover M., Brisman M., Walker E., Thomashunis A., Gonzalez J., The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus The New England Journal of Medicine 1993 329 14 977 986
4. Reichard P., Nilsson B. Y., Rosenquist U., The effect of long-term intensifie d insulin treatment on the development of microvascular complications of diabetes mellitus The New England Journal of Medicine 1993 329 304 309
5. Gavi III J. R., Roth J., Neville D. M. Jr., Insulin dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture Proceedings of the National Academy of Sciences of the United States of America 1974 71 1 84 88
6. Zick Y., Grunberger G., Podskalny J. M., Insulin stimulates phosphorylation of serine residues in soluble insulin receptors Biochemical and Biophysical Research Communications 1983 116 3 1129 1135
7. Kusari J., Kenner K. A., Suh K.-I., Hill D. E., Henry R. R., Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase1B protein content are associated with insulin action and resistance Journal of Clinical Investigation 1994 93 3 1156 1162
8. Zick Y., Insulin resistance: a phosphorylation-based uncoupling of insulin signaling Trends in Cell Biology 2001 11 11 437 441
9. Chevlen E., Opioids: a review Current Pain and Headache Reports 2003 7 1 15 23
10. Yaksh T. L., Pharmacology and mechanisms of opioid analgesic activity Acta Anaesthesiologica Scandinavica 1997 41 1 94 111
11. Smith E. M., Opioid peptides in immune cells Advances in Experimental Medicine and Biology 2003 521 51 68
12. Eigler N., Sacca L., Sherwin R. S., Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog. A model for stress-induced hyperglycemia Journal of Clinical Investigation 1979 63 1 114 123
13. Li C. H., Chung D., Doneen B. A., Isolation, characterization and opiate activity of endorphin from human pituitary glands Biochemical and Biophysical Research Communications 1976 72 4 1542 1547
14. Giugliano D., Cozzolino D., Salvatore T., Ceriello A., Torella R., Dual effect of beta-endorphin on insulin secretion in man Hormone and Metabolic Research 1987 19 10 502 503
15. Khawaja X. Z., Green I. C., Dual action of beta-endorphin on insulin release in genetically obese and lean mice Peptides 1991 12 2 227 233
16. Paolisso G., Giugliano D., Scheen A. J., Primary role of glucagon release in the effect of β-Endorphin on glucose homeostasis in normal man Acta Endocrinologica 1987 115 2 161 169
17. Radosevich P. M., Williams P. E., McRae J. M., β-Endorphin inhibits glucose production in the conscious dog Journal of Clinical Investigation 1984 73 4 1237 1241
18. Curry D. L., Bennett L. L., C. H. LI., Stimulation of insulin secretion by beta-endorphins ((1-27) (1-31)) Life Sciences 1987 40 21 2053 2058
19. Wohaieb S. A., Godin D. V., Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment Diabetes 1987 36 9 1014 1018
20. Kapusta D. R., Jones S. Y., DiBona G. F., Opioids in the systemic hemodynamic and renal responses to stress in conscious spontaneously hypertensive rats Hypertension 1989 13 6 808 816
21. McCubbin J. A., Surwit R. S., Williams R. B., Nemeroff C. B., McNeilly M., Altered pituitary hormone response to naloxone in hypertension development Hypertension 1989 14 6 636 644
22. Naranjo J. R., Urdin M. C., Borrell J., Fuentes J. A., Evidence for a central but not adrenal, opioid mediation in hypertension induced by brief isolation in the rat Life Sciences 1986 38 21 1923 1930
23. Eliasson K., Stress and catecholamines Acta Medica Scandinavica 1984 215 3 197 204
24. Liu I. M., Niu C. S., Chi T. C., Kuo D. H., Cheng J. T., Investigations of the mechanism of the reduction of plasma glucose by cold-stress in streptozotocin-induced diabetic rats Neuroscience 1999 92 3 1137 1142
25. Ableitner A., Schulz R., Neuroanatomical sites mediating the central actions of β-Endorphin as mapped by changes in glucose utilization: involvement of mu opioid receptors Journal of Pharmacology and Experimental Therapeutics 1992 262 1 415 423
26. Khan S., Evans A. A. L., Hughes S., Smith M. E., β-Endorphin decreases fatigue and increases glucose uptake independently in normal and dystrophic mice Muscle and Nerve 2005 31 4 481 486
27. Evans A. A. L., Khan S., Smith M. E., Evidence for a hormonal action of β-Endorphin to increase glucose uptake in resting and contracting skeletal muscle Journal of Endocrinology 1997 155 2 387 392
28. Evans A. A. L., Tunnicliffe G., Knights P., Bailey C. J., Smith M. E., Delta opioid receptors mediate glucose uptake in skeletal muscles of lean and obese-diabetic (ob/ob) mice Metabolism 2001 50 12 1402 1408
29. Evans A. A. L., Smith M. E., Opioid receptors in fast and slow skeletal muscles of normal and dystrophic mice Neuroscience Letters 2004 366 3 339 341
30. Liu I.-M., Chi T.-C., Shiao G.-C., Lin M.-T., Cheng J.-T., Loss of plasma glucose lowering response to cold stress in opioid -receptor knock-out diabetic mice Neuroscience Letters 2001 307 2 81 84
31. Guillemin R., Vargo T., Rossier J., endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland Science 1977 197 4311 1367 1369
32. Bunn S. J., Marley P. D., Livett B. G., The distribution of opioid binding subtypes in the bovine adrenal medulla Neuroscience 1988 27 3 1081 1094
33. Piascik M. T., Guarino R. D., Smith M. S., Soltis E. E., Saussy D. L. Jr., Perez D. M., The specific contribution of the novel alpha-1D adrenoceptor to the contraction of vascular smooth muscle Journal of Pharmacology and Experimental Therapeutics 1995 275 3 1583 1589
34. Viveros O. H., Diliberto E. J. Jr., Hazum E., Chang K. J., Opiate-like materials in the adrenal medulla: evidence for storage and secretion with catecholamines Molecular Pharmacology 1979 16 3 1101 1108
35. Yang H. Y.T., Di Giulio A. M., Fratta W., Enkephalin in bovine adrenal gland: multiple molecular forms of [ met5 ]-enkephalin immunoreactive peptides Neuropharmacology 1980 19 2 209 215
36. Furuta H., Direct evidence of -adrenoceptors binding in rat and human adrenal glands Nippon Hinyokika Gakkai Zasshi 1990 81 2 161 169
37. Cheng J. T., Liu I. M., Chi T. C., Tzeng T. F., Release of β-Endorphin by prostaglandin E2 to lower plasma glucose in streptozotocin-induced diabetic rats Hormone and Metabolic Research 2001 33 7 439 443
38. Cheng J.-T., Liu I.-M., Kuo D.-H., Lin M.-T., Stimulatory effect of phenylephrine on the secretion of β-Endorphin from rat adrenal medulla in vitro Autonomic Neuroscience 2001 93 1-2 31 35
39. Arefolov V. A., Dmitriev A. D., Tennov A. V., Val'dman A. V., Detection of the pro-opiomelanocortin peptide fragmentsbeta-endorphin and ACTHin the adrenals of rats and mice by immunohistochemistry Biulleten' Eksperimental'noi Biologii i Meditsiny 1986 101 4 445 447
40. Mitsuma T., Nogimori T., Sun D. H., Chaya M., Thyrotropin-releasing hormone reduces the plasma levels of β-Endorphin-like immunoreactivity in rats Experimental and Clinical Endocrinology 1987 89 1 55 60 (Pubitemid 17074004)
41. Hieble J. P., Bylund D. B., Clarke D. E., Eikenburg D. C., Langer S. Z., Lefkowitz R. J., Minneman K. P., Ruffolo R. R. Jr., International union of pharmacology. X. Recommendation for nomenclature of 1 -adrenoceptors: consensus update Pharmacological Reviews 1995 47 2 267 270
42. Minneman K. P., Han C., Abel P. W., Comparison of 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB 4101 Molecular Pharmacology 1988 33 5 509 514
43. Smallridge R. C., Kiang J. G., Gist I. D., Fein H. G., Galloway R. J., U-73122, an aminosteroid phospholipase C antagonist, noncompetitively inhibits thyrotropin-releasing hormone effects in GH3 rat pituitary cells Endocrinology 1992 131 4 1883 1888
44. Muto Y., Nagao T., Urushidani T., The putative phospholipase C inhibitor U73122 and its negative control, U73343, elicit unexpected effects on the rabbit parietal cell Journal of Pharmacology and Experimental Therapeutics 1997 282 3 1379 1388
45. Herbert J. M., Augereau J. M., Gleye J., Maffrand J. P., Chelerythrine is a potent and specific inhibitor of protein kinase C Biochemical and Biophysical Research Communications 1990 172 3 993 999
46. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F., Duhamel L., Charon D., Kirilovsky J., The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C Journal of Biological Chemistry 1991 266 24 15771 15781
47. Cotecchia S., Schwinn D. A., Randall R. R., Lefkowitz R. J., Caron M. G., Kobilka B. K., Molecular cloning and expression of the cDNA for the hamster 1-adrenergic receptor Proceedings of the National Academy of Sciences of the United States of America 1988 85 19 7159 7163
48. Lomasney J. W., Cotecchia S., Lorenz W., Leung W.-Y., Schwinn D. A., Yang-Feng T. L., Brownstein M., Lefkowitz R. J., Caron M. G., Molecular cloning and expression of the cDNA for the 1A -adrenergic receptor: the gene for which is located on human chromosome 5 Journal of Biological Chemistry 1991 266 10 6365 6369
49. Morrow A. L., Creese I., Characterization of 1 -adrenergic receptor subtypes in rat brain: a reevaluation of [ 3H ]WB4101 and [ 3H ]prazosin binding Molecular Pharmacology 1986 29 4 321 330
50. Bylund D. B., Eikenberg D. C., Hieble J. P., Langer S. Z., Lefkowitz R. J., Minneman K. P., Molinoff P. B., Ruffolo R. R. Jr., Trendelenburg U., IV. International union of pharmacology nomenclature of adrenoceptors Pharmacological Reviews 1994 46 2 121 136
51. Ford A. P. D. W., Williams T. J., Blue D. R., Clarke D. E., 1-adrenoceptor classification: sharpening Occam's razor Trends in Pharmacological Sciences 1994 15 6 167 170
52. Muramatsu I., Taniguchi T., Okada K., Tamsulosin: 1 -adrenoceptor subtype-selectivity and comparison with terazosin Japanese Journal of Pharmacology 1998 78 3 331 335
53. Khachaturian H., Lewis M. E., Tsou K., Watson S. J., Bjrklund A, Hkfelt T, β-Endorphin, -MSH, ACTH and related peptides Handbook of Chemical Anatomy 1985 4 Amsterdam, The Netherlands Elsevier 216 72
54. Schultzberg M., Lundberg J. M., Hokfelt T., Enkephalin-like immunoreactivity in gland cells and nerve terminals of the adrenal medulla Neuroscience 1978 3 12 1169 1186
55. Hsu C.-T., Liu I.-M., Cheng J.-T., Increase of β-Endorphin biosynthesis in the adrenal gland of streptozotocin-induced diabetic rats Neuroscience Letters 2002 318 2 57 60
56. Cheung C. Y., Tang F., The effect of streptozotocin-diabetes on β-Endorphin level and proopiomelanocortin gene expression in the rat pituitary Neuroscience Letters 1999 261 1-2 118 120
57. Law V., Payne L. C., Weigent D. A., Effects of streptozotocin-induced diabetes on lymphocyte POMC and growth hormone gene expression in the rat Journal of Neuroimmunology 1994 49 1-2 35 44
58. Cheng J. T., Liu I. M., Tzeng T. F., Tsai C. C., Lai T. Y., Plasma glucose-lowering effect of β-Endorphin in streptozotocin-induced diabetic rats Hormone and Metabolic Research 2002 34 10 570 576
59. Liu I.-M., Chi T.-C., Chen Y. C., Lu F.-H., Cheng J.-T., Activation of opioid -receptor by ioperamide to lower plasma glucose in streptozotocin-induced diabetic rats Neuroscience Letters 1999 265 3 183 186
60. Cheng J.-T., Liu I.-M., Chi T.-C., Tzeng T.-F., Lu F.-H., Chang C. J., Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats Diabetes 2001 50 12 2815 2821
61. Strother A., Throckmorton J. K., Herzer C., The influence of high sugar consumption by mice on the duration of action of barbiturates and in vitro metabolism of barbiturates, aniline and p-nitroanisole Journal of Pharmacology and Experimental Therapeutics 1971 179 3 490 498
62. Strother A., Chau L. S. K., Influence of glucose (in vivo or in vitro) on duration of narcotic analgesics and on the kinetics of drug metabolism Pharmacology 1980 21 3 161 166
63. Gosnell B. A., Grace M., Billington C. J., Levine A. S., Effects of streptozotocin-induced diabetes on feeding stimulated by centrally administered opioid agonists Life Sciences 1989 45 1 31 40
64. Simon G. S., Dewey W. L., Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine Journal of Pharmacology and Experimental Therapeutics 1981 218 2 318 323
65. Kamei J., Ohhashi Y., Aoki T., Kawasima N., Kasuya Y., Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by -opioid agonists, but not by -and -opioid agonists Brain Research 1992 571 2 199 203
66. Thomas P. K., Classification, differential diagnosis, and staging of diabetic peripheral neuropathy Diabetes 1997 46 2 S54 S57
67. Hughes S., Smith M. E., Bailey C. J., β-Endorphin and corticotropin immunoreactivity and specific binding in the neuromuscular system of obese-diabetic mice Neuroscience 1992 48 2 463 468
68. Hughes S., Smith M. E., Bailey C. J., POMC-derived peptides in the neuromuscular system of streptozotocin-diabetic mice Peptides 1992 13 5 873 877
69. Cheng J.-T., Liu I. M., Chi T. C., Tzeng T. F., Increase of opioid -receptor gene expression in streptozotocin-induced diabetic rats Hormone and Metabolic Research 2001 33 8 467 471
70. Ziel F. H., Venkatesan N., Davidson M. B., Glucose transport is rate limiting for skeletal muscle glucose metabolism in normal and STZ-induced diabetic rats Diabetes 1988 37 7 885 890
71. Berger J., Biswas C., Vicario P. P., Strout H. V., Saperstein R., Pilch P. F., Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting Nature 1989 340 6228 70 72
72. Tzeng T. F., Liu I. M., Lai T. Y., Tsai C. C., Chang W. C., Cheng J. T., Loperamide increases glucose ultilization in streptozotocin-induced diabetic rats Clinical and Experimental Pharmacology and Physiology 2003 30 10 734 738
73. Bollen M., Keppens S., Stalmans W., Specific features of glycogen metabolism in the liver Biochemical Journal 1998 336 1 19 31
74. Consoli A., Nurjhan N., Capani F., Gerich J., Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM Diabetes 1989 38 5 550 557 (Pubitemid 19125601)
75. Xie W., Samoriski G. M., McLaughlin J. P., Romoser V. A., Smrcka A., Hinkle P. M., Bidlack J. M., Gross R. A., Jiang H., Wu D., Genetic alteration of phospholipase C 3 expression modulates behavioral and cellular responses to opioids Proceedings of the National Academy of Sciences of the United States of America 1999 96 18 10385 10390
76. Liu I. M., Liou S. S., Chen W. C., Chen P. F., Cheng J. T., Signals in the activation of opioid μ-receptors by loperamide to enhance glucose uptake into cultured C2C12 Cells Hormone and Metabolic Research 2004 36 4 210 214
77. Goodyear L. J., Hirshman M. F., Smith R. J., Horton E. S., Glucose transporter number, activity, and isoform content in plasma membranes of red and white skeletal muscle American Journal of Physiology 1991 261 5 E556 E561
78. Sivitz W. I., DeSautel S. L., Kayano T., Bell G. I., Pessin J. E., Regulation of glucose transporter messenger RNA in insulin-deficient states Nature 1989 340 6228 72 74
79. Mountjoy K. G., Housey G. M., Flier J. S., Overproduction of the 1 form of protein kinase C enhances phorbol ester induction of glucose transporter mRNA Molecular Endocrinology 1989 3 12 2018 2027
80. Attwood P. V., Keech D. B., Pyruvate carboxylase Current Topics in Cellular Regulation 1984 23 1 55
81. Hanson R. W., Reshef L., Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression Annual Review of Biochemistry 1997 66 581 611
82. Agati J. M., Yeagley D., Quinn P. G., Assessment of the roles of mitogen-activated protein kinase, phosphatidylinositol 3-kinase, protein kinase B, and protein kinase C in insulin inhibition of cAMP-induced phosphoenolpyruvate carboxykinase gene transcription Journal of Biological Chemistry 1998 273 30 18751 18759
83. Cheng J.-T., Liu I.-M., Stimulatory effect of caffeic acid on (1A)-adrenoceptors to increase glucose uptake into cultured C2C12 cells Naunyn-Schmiedeberg's Archives of Pharmacology 2000 362 2 122 127
84. Cheng J. T., Liu I. M., Tzeng T. F., Chen W. C., Hayakawa S., Yamamoto T., Release of β-Endorphin by caffeic acid to lower plasma glucose in streptozotocin-induced diabetic rats Hormone and Metabolic Research 2003 35 4 251 258
85. Hsu F.-L., Chen Y.-C., Cheng J.-T., Caffeic acid as active principle from the fruit of Xanthium strumarium to lower plasma glucose in diabetic rats Planta Medica 2000 66 3 228 230
86. Liu I.-M., Chen W.-C., Cheng J.-T., Mediation of β-Endorphin by isoferulic acid to lower plasma glucose in streptozotocin-induced diabetic rats Journal of Pharmacology and Experimental Therapeutics 2003 307 3 1196 1204
87. Liu I.-M., Chi T.-C., Hsu F.-L., Chen C.-F., Cheng J.-T., Isoferulic acid as active principle from the rhizoma of Cimicifuga dahurica to lower plasma glucose in diabetic rats Planta Medica 1999 65 8 712 714
88. Liu I.-M., Hsu F.-L., Chen C.-F., Cheng J.-T., Antihyperglycemic action of isoferulic acid in streptozotocin-induced diabetic rats British Journal of Pharmacology 2000 129 4 631 636
89. Liu I.-M., Tsai C.-C., Lai T.-Y., Cheng J.-T., Stimulatory effect of isoferulic acid on 1A -adrenoceptor to increase glucose uptake into cultured myoblast C2C12 cell of mice Autonomic Neuroscience 2001 88 3 175 180
90. Hsu H.-H., Chang C.-K., Su H.-C., Liu I.-M., Cheng J.-T., Stimulatory effect of puerarin on 1A-adrenoceptor to increase glucose uptake into cultured C2C12 cells of mice Planta Medica 2002 68 11 999 1003
91. Hsu F.-L., Liu I.-M., Kuo D.-H., Chen W.-C., Su H.-C., Cheng J.-T., Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats Journal of Natural Products 2003 66 6 788 792
92. Chen W.-C., Hayakawa S., Yamamoto T., Su H.-C., Liu I.-M., Cheng J.-T., Mediation of β-Endorphin by the isoflavone puerarin to lower plasma glucose in streptozotocin-induced diabetic rats Planta Medica 2004 70 2 113 116
93. Yu B. C., Chang C. K., Su C. F., Cheng J. T., Mediation of β-Endorphin in andrographolide-induced plasma glucose-lowering action in type I diabetes-like animals Naunyn-Schmiedeberg's Archives of Pharmacology 2008 377 46 529 540
94. Yu B.-C., Hung C.-R., Chen W.-C., Cheng J.-T., Antihyperglycemic effect of andrographolide in streptozotocin-induced diabetic rats Planta Medica 2003 69 12 1075 1079
95. Hsu J.-H., Liou S.-S., Yu B.-C., Cheng J.-T., Wu Y.-C., Activation of 1A-adrenoceptor by andrographolide to increase glucose uptake in cultured myoblast C2C12 cells Planta Medica 2004 70 12 1230 1233
96. Liu I.-M., Liou S.-S., Cheng J.-T., Mediation of β-Endorphin by myricetin to lower plasma glucose in streptozotocin-induced diabetic rats Journal of Ethnopharmacology 2006 104 1-2 199 206
97. Liu I.-M., Liou S.-S., Lan T.-W., Hsu F.-L., Cheng J.-T., Myricetin as the active principle of Abelmoschus moschatus to lower plasma glucose in streptozotocin-induced diabetic rats Planta Medica 2005 71 7 617 621
98. Lai D.-M., Tu Y.-K., Liu I.-M., Chen P.-F., Cheng J.-T., Mediation of β-Endorphin by ginsenoside Rh2 to lower plasma glucose in streptozotocin-induced diabetic rats Planta Medica 2006 72 1 9 13
99. Niu H.-S., Hsu F.-L., Liu I.-M., Cheng J.-T., Increase of β-Endorphin secretion by syringin, an active principle of Eleutherococcus senticosus, to produce antihyperglycemic action in type 1-like diabetic rats Hormone and Metabolic Research 2007 39 12 894 898
100. Niu H.-S., Liu I.-M., Cheng J.-T., Lin C.-L., Hsu F.-L., Hypoglycemic effect of syringin from Eleutherococcus senticosus in streptozotocin-induced diabetic rats Planta Medica 2008 74 2 109 113
101. Clifford M. N., Chlorogenic acids and other cinnamatesnature, occurrence and dietary burden Journal of the Science of Food and Agriculture 1999 79 3 362 372
102. Graf E., Antioxidant potential of ferulic acid Free Radical Biology and Medicine 1992 13 4 435 448
103. Ozaki Y., Ma J.-P., Inhibitory effects of tetramethylpyrazine and ferulic acid on spontaneous movement of rat uterus in situ Chemical and Pharmaceutical Bulletin 1990 38 6 1620 1623
104. Bakovic M., Dunford H. B., Oxidation kinetics of caffeic acid by prostaglandin H synthase: potential role in regulation of prostaglandin biosynthesis Prostaglandins Leukotrienes and Essential Fatty Acids 1994 51 5 337 345
105. Chen Y.-F., Tsai H.-Y., Wu T.-S., Anti-inflammatory and analgesic activities from roots of Angelica pubescens Planta Medica 1995 61 1 2 8
106. Keung W. M., Vallee B. L., Kudzu root: an ancient Chinese source of modern antidipsotropic agents Phytochemistry 1998 47 4 499 506
107. Liu Q., Lu Z., Wang L., Restrictive effect of puerarin on myocardial infarct area in dogs and its possible mechanism Journal of Tongji Medical University 2000 20 1 43 45
108. Guerra M. C., Speroni E., Broccoli M., Cangini M., Pasini P., Minghetti A., Crespi-Perellino N., Mirasoli M., Cantelli-Forti G., Paolini M., Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin: antioxidant properties and effects on rat liver CYP-catalysed drug metabolism Life Sciences 2000 67 24 2997 3006
109. Lu X. R., Gao E., Xu L. Z., Puerarin beta-adrenergic receptor blocking effect Chinese Medical Journal 1987 100 1 25 8
110. Basak A., Cooper S., Roberge A. G., Banik U. K., Chrtien M., Seidah N. G., Inhibition of proprotein convertases-1, -7 and furin by diterpines of Andrographis paniculata and their succinoyl esters Biochemical Journal 1999 338 1 107 113
111. Visen P. K. S., Shukia B., Patnaik G. K., Dhawan B. N., Andrographolide protects rat hepatocytes against paracetamol-induced damage Journal of Ethnopharmacology 1993 40 2 131 136
112. Kapil A., Koul I. B., Banerjee S. K., Gupta B. D., Antihepatoxic effects of major diterpenoid constituents of Andrographis paniculata Biochemical Pharmacology 1993 46 1 182 185
113. Handa S. S., Sharma A., Hepatoprotective activity of Andrographolide from andrographis paniculata against carbontetrachloride Indian Journal of Medical Research 1990 92 276 283
114. Puri A., Saxena R., Saxena R. P., Saxena K. C., Srivastava V., Tandon J. S., Immunostimulant agents from Andrographis paniculata Journal of Natural Products 1993 56 7 995 999
115. Chiou W.-F., Chen C.-F., Lin J.-J., Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells by andrographolide British Journal of Pharmacology 2000 129 8 1553 1560